Navigation Links
Soligenix to Present at 13th Annual BIO CEO & Investor Conference
Date:2/9/2011

PRINCETON, N.J., Feb. 9, 2011 /PRNewswire/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will give a corporate presentation at the 2011 BIO CEO & Investor Conference on Monday, February 14, at 9:00 AM Eastern Standard Time.  The presentation will take place in the Duke of Windsor Room at the Waldorf Astoria Hotel in New York City.

The Soligenix presentation will be webcast live and archived for later replay. To access the webcast, please visit the company's investor page at http://www.soligenix.com/invest_sec.shtml.  A replay of the presentation will be archived after the conference at the same location.

For more information about the 2011 BIO CEO & Investor Conference, please refer to the conference website at http://www.bio.org/bioceo/.

About Soligenix, Inc.

Soligenix is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of hematopoietic cell transplantation. orBec® is currently the subject of a $1.2 million FDA Orphan Products Grant-supported confirmatory Phase 3 clinical trial for the treatment of acute GI GVHD. Soligenix is also conducting a National Cancer Institute (NCI)-supported Phase 1/2 clinical trial of SGX201 in the prevention of acute radiatio
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
10. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
11. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  WebMD ... leading source of health information, today announced ... new National Action Plan for Combating ... Obama emphasized the urgency and importance of ... national and global health.    The ...
(Date:3/26/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... Omega-3 therapies for cardiovascular disease and overall health, announced ... shares of the Corporation (the "Common Shares"). The Common ... December 5 th , 2014 to March 4 th ... due on or before April 1, 2015. Interest on ...
(Date:3/26/2015)... , March 26, 2015 "Whether it,s our ... one day." In a single sentence, ... scientific officer at Pfizer,s Centers for Therapeutic Innovation ... scientists fueling progress at America,s biopharmaceutical companies. ... side-by-side with academia, patient foundations and the National Institutes ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... Pain relieving effects of MoxDuo(TM) IR are ... with post-operative pain following total knee replacement , ... QRxPharma Limited (ASX: QRX) and (OTCQX: QRXPY) announced today ... efficacy and safety profile of MoxDuo(TM) IR (immediate release) capsules ...
... , THOUSAND OAKS, Calif., Aug. 25 Amgen (Nasdaq: ... double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease ... rial to R educe Cardiovascular E ndpoints with ... Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had ...
Cached Medicine Technology:MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R) 2MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R) 3MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R) 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8
(Date:3/30/2015)... A new recruitment site has been launched ... next career move. , Millions of new jobs are ... with skills in the booming data and analytics sectors.* ... jobs aggregator, pulling in opportunities from both employers and ... to help candidates find suitable big data and analytics ...
(Date:3/30/2015)... 30, 2015 BioFit ... and manufacturer of ergonomic seating solutions, now ... The new upholsteries bolster the company’s existing ... seating, providing disinfectable, green choices. , The ... textile purveyor CF Stinson. Six disinfectable patterns ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Bunion Bootie ... discomfort. Buy them for family members, friends...and yourself and save. ... customers can save an additional 10%, on top of discounts ... promo code "EasterPR" at checkout. The more Bunion Booties purchased, ... toe spacers, and bunion pads, Bunion Bootie can be worn ...
(Date:3/29/2015)... Calif. (PRWEB) March 30, 2015 Over ... menopause-related symptoms tied to undiagnosed autoimmune, thyroid, or hormone ... thyroid disorders, has personally treated hundreds of patients dealing ... are unaware of the treatment options for their ailments. ... offers solutions to women living with fatigue, brain fog, ...
(Date:3/29/2015)... Birmingham, Lake Orion, Clarkston, Metamora, MI. (PRWEB) March 29, ... affiliated with Beaumont Hospital , offers comprehensive endometriosis ... now offer patients in that area a closer hospital ... St. Joseph Mercy Oakland and McLaren Oakland. ... tissue that normally lines the inside of the uterus ...
Breaking Medicine News(10 mins):Health News:New Global Job Site Launched for Big Data and Analytics Job Seekers 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Bunion Bootie, the Ultimate Solution for Bunion Relief, Offers Special Savings This Easter 2Health News:How to Turn Mid-life into the Good Life 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Endometriosis 2
... Institute of Technology Kanpur have discovered that the mechanism that ... stream can, in certain circumstances, collapse into a state which ... This process could provide the first insight into how iron ... Parkinsons & Alzheimers and Huntingtons diseases. , Human blood relies ...
... Products,Inc. (Nasdaq: AHPI ) reported today that its net ... percent from $293,000 last year,or 4 cents per share, to ... For the first half of the 2008 fiscal year ... $495,000 last year, or six cents,per share, to about $93,500, ...
... 8 Today, Congresswoman,Stephanie Tubbs Jones announced that ... for the Louis Stokes Cleveland VA Medical,Center by ... the new,construction was made possible by a $397 ... construction under the final 2008,Appropriations bill signed into ...
... tool powered by SNAPforSeniors(R) helps members quickly,locate safe housing, ... rash of tornadoes in more than 20 years destroyed ... Tennessee Tuesday night., Emergency warnings gave most residents ... housing, natural disasters bring extra fears. Lack,of mobility, limited ...
... Inc. (Nasdaq:,HWKN) today announced third quarter and nine months ... 2007, Hawkins reported sales,increased 30.9% to $48.5 million versus ... income for the quarter was $1.5 million, equal to ... $0.03 per diluted share,for the third quarter of fiscal ...
... sleep disturbances , , FRIDAY, Feb. 8 (HealthDay News) -- ... as bad as what people experience when they stop ... new study says. , "These results indicate that ... to quit, and that these effects should be considered ...
Cached Medicine News:Health News:Iron banded worms drying out of blood could be linked to Parkinson's and Alzheimer's 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 2Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 3Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 4Health News:Allied Healthcare's Net Suffers on Flat Sales, Performance Issues 5Health News:Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 2Health News:Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 3Health News:Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results 2Health News:Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results 3Health News:Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results 4Health News:Quitting Marijuana Just as Hard as Quitting Cigarettes 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: